J&J pleads guilty in Natrecor marketing case
(Reuters) – Johnson and Johnson has agreed to pay $85 million and plead guilty to U.S. government charges that it marketed heart drug Natrecor for unapproved uses, according to court documents.
September 14th, 2011
Posted in
Drug